Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The AIDS infection in Brazil is unique because of the high incidence of isolates with an unusual motif (GWGR) at the V3 region of the env gene.
|
20874421 |
2011 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
Here, we sequenced the gp120 coding region of nine full-length dual-tropic (R5X4) env genes cloned directly from autopsy brain and spleen tissue from an AIDS patient with severe HAD.
|
18788913 |
2008 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunogenic, broadly reactive epitopes of the HIV-1 envelope glycoprotein could serve as important targets of the adaptive humoral immune response in natural infection and, potentially, as components of an acquired immune deficiency syndrome vaccine.
|
15867093 |
2005 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Deletions in env gene of HIV-1 in AIDS patients treated with highly active antiretroviral therapy (HAART).
|
12938189 |
2003 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
A chimeric simian-human immunodeficiency virus (SHIV-4) containing the tat, rev, vpu, and env genes of HIV type 1 (HIV-1) in a genetic background of SIVmac239 was used to develop an animal model in which a primate lentivirus expressing the HIV-1 envelope glycoprotein caused acquired immune deficiency syndrome (AIDS) in macaques.
|
10087226 |
1999 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients.
|
7504074 |
1993 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
Follicular dendritic cells (FDC) from axillary lymphoid tissue of a patient with acquired immune deficiency syndrome (AIDS) were analyzed for the presence of gag and env proteins and env mRNA of human immunodeficiency virus type-1 (HIV-1), both in a purified FDC suspension and on frozen sections.
|
2117396 |
1990 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
This hybrid protein displays selective toxicity toward cells expressing the HIV envelope glycoprotein and thus represents a promising novel therapeutic agent for the treatment of AIDS.
|
2843774 |
1988 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
The final preparation of gag and gag/env proteins in 8 M urea reacted with sheep anti-HTLV-III p24 gag antibodies and acquired immune deficiency syndrome (AIDS) patient sera.
|
3495201 |
1987 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
Envelope glycoprotein purified from culture fluids was immunogenic in laboratory animals in both native and PAGE-purified forms and was reactive with AIDS patient sera in immunoassays.
|
2833915 |
1987 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
Within the AIDS virus env gene, the surface glycoprotein region is more liable to vary than is the transmembrane region; unexpectedly, however, this liability is not a characteristic feature of the AIDS virus because it is more prominent in other retroviruses including members of the HTLV/BLV family.
|
3009215 |
1986 |
Acquired Immunodeficiency Syndrome
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The origin and clinical implications of the AIDS viral env gene diversity are discussed.
|
3014529 |
1986 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
All polypeptides containing the ENV(80) sequences were strongly reactive with antibodies present in sera from AIDS virus-infected individuals, but not with control sera.
|
3491755 |
1986 |
Acquired Immunodeficiency Syndrome
|
0.100 |
Biomarker
|
group |
BEFREE |
HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients.
|
2988795 |
1985 |